References
- Bockbrader HN, Budhwani MN, Wesche DL. Gabapentin to pregabalin therapy transition: a pharmacokinetic simulation. Am J Ther 2013;20:32-6
- D’Urso De Cruz E, Dworkin RH, Stacey B, et al. Treatment of painful diabetic peripheral neuropathy and postherpetic neuralgia with pregabalin in treatment-refractory patients: findings from a long- term open-label trial. Arch Phys Med Rehabil 2005;86:E34
- Brummel RN, Singh L. A synergistic combination: gabapentin and pregabalin. European patent specification. Publication number: EP1196160 B1. December 2005
- Crosta P. What is Lyrica (pregabalin)? Uses, dosage, and side effects. Medical News Today. May 2017. Available at: https://www.medicalnewstoday.com/articles/151139.php Accessed on: July 2017
- Moore RA, Wiffen PJ, Derry S, et al. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2014;27:CD007938
- Finnerup NB, Jensen TS. Clinical use of pregabalin in the management of central neuropathic pain. Neuropsychiatr Dis Treat 2007;3:885-91
- Pregabalin drug information. Parke-Davis Division of Pfizer Inc. September 2017. Available at: https://www.uptodate.com/contents/pregabalin-drug-information?source=preview&search=pregabalin&anchor=F949966#F949966 Accessed on: July 2017
- Goodman CW, Brett AS. Gabapentin and pregabalin for pain – is increased prescribing a cause for concern? N Engl J Med 2017;377:411-14
- Kehlet H. Enhanced recovery programmes: why, how and for what? Reg Anesth Pain Med 2017;42:pe1-200
- Evoy EK, Morrison MD, Saklad SR. Abuse and misuse of pregabalin and gabapentin. Drugs 2017;77:403-26
- Lowther C. Pregabalin (Lyrica): Part I. September/October 2005. Available at: http://www.clevelandclinicmeded.com/medicalpubs/pharmacy/septoct2005/pregabalin.htm Accessed on: July 2017
- Bockbrader HN, Wesche D, Miller R, et al. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet 2010;49:661-9
- Mack A. Examination of the evidence for off-label use of gabapentin. J Manag Care Pharm 2003;9:559-68
- Verma V, Singh N, Singh Jaggi A. Pregabalin in neuropathic pain: evidences and possible mechanisms. Curr Neuropharmacol 2014;12:44-56
- Raouf M, Atkinson TJ, Crumb MW, Fudin J. Rational dosing of gabapentin and pregabalin in chronic kidney disease. J Pain Res 2017;10:275-8
- Lyrica – pregabalin capsule. Archived Drug Label. September 2010. Available at: https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid =41099 Accessed on: May 2017
- Wallin J, Cui JG, Yakhnitsa V, et al. Gabapentin and pregabalin suppress tactile allodynia and potentiate spinal cord stimulation in a model of neuropathy. Eur J Pain 2002;6:261-72
- Tanabe M, Takasu K, Takeuchi Y, et al. Pain relief by gabapentin and pregabalin via supraspinal mechanisms after peripheral nerve injury. J Neurosci Res 2008;86:3258-64
- Wesche D, Bockbrader H. A pharmacokinetic comparison of pregabalin and gabapentin. J Pain 2005;6:S29
- Rose MA, Kam PC. Gabapentin: pharmacology and its use in pain management. Anaesthesia 2002;57:451-62
- Sutton KG, Martin DJ, Pinnock RD, et al. Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones. Br J Pharmacol 2002;135:257-65
- Hurley RW, Chatterjea D, Rose Feng M, et al. Gabapentin and pregabalin can interact synergistically with naproxen to produce antihyperalgesia. Anesthesiology 2002;97:1263-73